This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
|Zacks Rank||Definition||Annualized Return|
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at firstname.lastname@example.org or call 800-767-3771 ext. 9339.
Genesco sells footwear, sports apparel, headwear and accessories at more than 22,000 locations. Brands include Journeys, Lids and several others.
Since GCO was featured as a Zacks Rank Buy, back in June, the company posted another earnings surprise. Quarterly results came out on Aug 31 and showed earnings per share of $0.22, 12 cents better than expected. The company now has 4 consecutive earnings surprises.
Sales grew 29% to $471 million thanks in part to a 14% jump in same-store sales.
Raising the Outlook
In the same press release the company raised its full-year outlook. Genesco added 45 cents to both ends of the range which is now at $3.35-$3.42.
After a round of upward revisions, the fiscal 2012 Zacks Consensus Estimate is right in the middle of that range, at $3.39. The 2013 estimates are averaging $4.03, up 11 cents. If Genesco can hit those targets, EPS growth rates will be 37% and 19%, respectively.
Shares of GCO are going for 15 times the forward estimates and that gives them a PEG ratio of 1.0. The price to sales ratio is a solid 0.6 and the stock is going for 1.8 times book value.
You can see below that the initial reaction to the earnings surprise was very bullish. Unfortunately, stocks don't trade in a vacuum and GCO was dragged down by the market. However, this gives investors a good chance to get in at a lower price.
Bill Wilton is the Aggressive Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the Zacks Small Cap Trader service
This Week's Aggressive Growth Zacks Rank Buy Stocks
HealthSpring (HS) analysts are getting more and more bullish even as the market is gripped with fear. Estimates moving higher, plus shares moving lower equals excellent valuations for this Zacks #1 Rank (Strong Buy).
Luminex (LMNX) has seen strength across all of its segments that led to a third consecutive earning surprise.
Some valuations are a bit lofty, but a slight pull back could make for a great entry point for shares of LMNX.
Complete Production Services (CPX) may have fallen out of favor with the market, but if you are looking for a steal this Zacks #1 Rank (Strong Buy) is a great option.
Estimates are rising despite economic worries, which have led to great valuations and should result in fantastic gains.
Please login to Zacks.com or register to post a comment.